Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Bowman Consulting Group Ltd said on Monday that it had entered into a definitive agreement to acquire Blankinship & Associates.

Founded in 2000 and based in Davis, California, Blankinship is an environmental sciences and engineering company that specializes in providing water resources services, natural resource management services as well as permitting and compliance services.

Blankinship’s staff of professionals will all become part of Bowman Consulting Group’s team.

Funded via a combination of cash, seller notes and equity, the acquisition falls within previously discussed target multiple and operating metric ranges and is expected to be immediately accretive, Bowman said.

”Mike and his team have a unique set of skills and specialties that have been honed during his more than 20 years in business,” Gary Bowman, Chairman and Chief Executive Officer of Bowman Consulting Group, said in a press release.

”Their reputation as a leading source of environmental sciences and engineering services was what originally drew us to Blankinship, but as we got to know them it was their professionalism and unrelenting can-do culture that compelled us to make them part of Bowman. Their practice will be of immediate value in every aspect of our business, and we expect there to be significant revenue synergy and wallet-share expansion opportunities created by this acquisition,” the CEO added.

”I started our firm so we could tell a better story to regulators, our clients and our community about how environmental science solves real world problems. Gary and the Bowman team share our desire to create common sense solutions that address complex environmental challenges. I believe our team will make great contributions toward helping Bowman clients tackle their environmental and natural resources issues through consultation, innovation, and simplification,” Mike Blankinship, Founder and President of Blankinship & Associates, said.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Gold Breaks $5,000, Sets Fresh Record HighGold Breaks $5,000, Sets Fresh Record High Key Moments Spot gold climbed 1.1% to a record $5,035.83/oz, while U.S. futures hit $5,074.71/oz. Last week, gold jumped more than 8% and is now up nearly 17% for the year. Geopolitical tensions, tariff threats, and […]
  • CHF/RUB settles below 1-week high, posts weekly lossCHF/RUB settles below 1-week high, posts weekly loss The CHF/RUB currency pair settled below recent high of 101.431, its strongest level since April 17th, in the wake of the Bank of Russia’s policy decision.The Bank of Russia (CBR) left its key policy rate without change at a record high of […]
  • Copper futures swing on Yellen comments, disappointing Euro zone growthCopper futures swing on Yellen comments, disappointing Euro zone growth Copper swung between gains and losses on Thursday after President Barack Obama’s nominee to lead the Federal Reserve, Janet Yellen, backed Fed’s monetary easing program and curbed speculations for an earlier-than-expected stimulus tapering, […]
  • Forex Market: CAD/MXN daily trading forecastForex Market: CAD/MXN daily trading forecast Yesterday’s trade saw CAD/MXN within the range of 11.9359-11.9859. The pair closed at 11.9776, gaining 0.01% on a daily basis.At 7:08 GMT today CAD/MXN was up 0.05% for the day to trade at 11.9812. The pair touched a daily high at 11.9908 […]
  • Gold extends gains, but eyes largest monthly loss since 2008Gold extends gains, but eyes largest monthly loss since 2008 Spot Gold extended gains on Tuesday as some optimism over de-escalation in the Middle East conflict has emerged.Yet, the metal was on course for its steepest monthly drop since October 2008 due to a firmer US Dollar and diminishing […]
  • Regeneron shares surge in premarket, company to start trials of COVID-19 antibody treatmentRegeneron shares surge in premarket, company to start trials of COVID-19 antibody treatment Shares in Regeneron Pharmaceuticals gained 2.69% in premarket trading Thursday. The company piqued investors’ interest as it announced the start of its first clinical trials of antibody combinations for the treatment of COVID-19.The […]